Seoul Semiconductor Sues Big-Box TV Retailer for Infringement of 15 LED Patents in U.S. Court
Seoul Semiconductor (KOSDAQ:046890), a leading global innovator of LED products and technology, announced that it has filed a patent infringement lawsuit in the United States District Court for the Eastern District of Texas, together with its affiliate, Seoul Viosys Co., Ltd. (collectively “Seoul”), against Fry’s Electronics (“Fry’s”), a retail company of consumer electronics. The patent litigation concerns Fry’s sales of various LED television products.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180904005182/en/
Seoul Semiconductor's Key Patented Technologies for TV Backlight (Graphic: Business Wire)
Fry’s is one of the largest big-box retailer of consumer electronics in the United States. It has 17 mega-stores in California and 14,000 employees. Fry’s currently offers more than 300 LED television models featuring twenty-five different global TV brands.
In its complaint, Seoul asserts that certain LED TV products in Fry’s stores infringe 15 of Seoul’s LED patents that relate to manufacturing processes for LED backlight units. Seoul’s patented technologies cover LED TV backlight unit structures, LED backlight lenses for providing uniform illumination of LED lights, UCD technology for high color gamut displays, LED packaging, LED chip fabrication, and LED epitaxy. These are significant technologies to improve the color, brightness, and duration time of all LCD light sources such as smartphones, laptops, tablet PCs and monitors as well as TVs.
In particular, optical lens technology for offering uniform light distribution on TV or monitor displays is one of the most significant LED backlight technologies that Seoul has developed since the earliest days of LCD backlights.
In order to protect that patented technology, Seoul actively enforces its patent rights against suspected-infringers. For example, in 2016, Seoul prevailed in U.S. federal court against Japanese lens maker, Enplas, with a judgment finding that Enplas willfully infringed one of Seoul’s LED backlight lens patents, as well as one of Seoul’s LED backlight system patents. Over the past few years, Seoul has also pursued patent litigation for infringement of LED backlight lens and other components patents against North America TV maker Craig Electronics and Curtis International and successfully obtained patent royalties from both companies.
UCD technology (KSF) is another of Seoul's core LED backlight technologies that enables significant improvement of color gamut of LCD displays such as TVs and smartphones, which has been co-developed with a Japanese corporation for a long time. By enabling green and red light generated with KSF phosphors, UCD technology delivers 92-93% NTSC, which is higher than that of OLED.
Prior to the filing of its most recent litigation, Seoul delivered notices of patent infringement to various global TV brand makers, as well as their suppliers who manufacture TV modules or TV sets in various regions of Asia, including China and Taiwan, through OEM or ODM. Seoul advised these TV makers and manufacturers that they needed to stop using LEDs and/or other components that likely infringe Seoul’s LED backlight lens and UCD technology patents.
“For young entrepreneur and small business entities to develop innovative products under fair competition culture, it is necessary for market participants to respect other companies’ intellectual property rights,” said Sam Ryu, Seoul’s Vice President of IT Business. “To prevent distribution of suspected-infringing products, we are thoroughly investigating various global TV brand products that may infringe our patents. If these companies continue to use products that are suspected of infringement, despite our requests to stop, we will take all the necessary legal actions to the end.”
About Seoul Semiconductor
Seoul Semiconductor develops and commercializes LEDs for automotive, general illumination, specialty lighting, and backlighting markets. As the fourth-largest LED manufacturer globally, Seoul Semiconductor holds more than 12,000 patents, offers a wide range of technologies, and products such as SunLike – delivering the world’s best light quality in a next-generation LED enabling human-centric lighting optimized for circadian rhythms; WICOP – a simpler structured package-free LED which provides market leading color uniformity and cost savings at the fixture level, providing high lumen density and design flexibility; NanoDriver Series – the world’s smallest 24W DC LED drivers; Acrich, the world's first high-voltage AC-driven LED technology developed in 2005, including all AC LED-related technologies from chip to module and circuit fabrication, as well as multi-junction technology (MJT); and nPola, a new LED product based on GaN-substrate technology that achieves more than ten times the output of conventional LEDs. UCD constitutes a high color gamut display which delivers more than 90% NTSC.
Seoul Semiconductor Inc.
Jeonghee Kim, +82-70-4391-8311
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Telefónica Deutschland Selects SIAE MICROELETTRONICA for Turn-Key DCN Migration Services in Germany19.11.2018 11:00 | Tiedote
Telefónica Deutschland , a leading integrated telecommunications provider in Germany awards SIAE MICROELETTRONICA, a long-term strategic partner for wireless transmission solutions, a turn-key contract for DCN (Data Communication Networks) migration services across its backhaul network. Following the successful acquisition of E-Plus, Telefónica Deutschland new backhaul network counts over 30.000 microwave radio links from three different vendors, including SIAE MICROELETTRONICA. In preparation for a potential 5G launch in the future, Telefónica is taking steps to simplify operations and maximize performances and coherence across its network. With these activities Telefónica plans to update its DCN by implementing a new common-DCN architectural model. The migration services entrusted to SIAE MICROELETTRONICA include project- management, IP network design, new-model implementation and operation service delivery. The cluster-by-cluster migration process consists of a mix of remote configu
Dentons Global Chairman and Global Chief Executive Officer Re-Elected19.11.2018 11:00 | Tiedote
Dentons, the world's largest law firm, announced today that Joseph Andrew and Elliott Portnoy have been re-elected to three-year terms as Global Chairman and Global Chief Executive Officer, respectively. They have led the firm together since its formation in March 2013. Messrs. Andrew and Portnoy ran without opposition and have been the entrepreneurial drive and architects of Dentons’ client-centric strategy and polycentric approach to law firm management, resulting in a period of unprecedented growth while many law firms are contracting as they are buffeted by the changes shaping the legal profession globally. Under their leadership, Dentons has grown into the world’s largest law firm with more than 9,600 lawyers operating in 174 locations and 78 countries. During this same time, the firm has successfully completed dozens of business combinations throughout markets in Africa, ASEAN, Australia, Canada, Caribbean, China, Europe, Latin America, Middle East, United Kingdom and United Stat
Biosense Webster Launches Report - The Burden of Atrial Fibrillation: Understanding the Impact of the New Millennium Epidemic Across Europe19.11.2018 09:00 | Tiedote
Biosense Webster EMEA, a Division of Johnson & Johnson Medical NV/SA and leader in the treatment of Atrial Fibrillation (AF) has today, during AF Association Global AF Aware Week, published a report that uncovers the growing burden of AF on patients, caregivers and healthcare systems across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181118005008/en/ The new report is calling for greater awareness and emphasis on the scale and impact of AF which is fast becoming one of the world’s most significant health issues. The new millennium epidemic not only disrupts the quality of life for the 11 million people across Europe who suffer from AF, but also costs healthcare systems up to €3,286 million annually across European countries.2-7 AF is characterized by an irregular and often fast heart rhythm that results in uncoordinated contraction of the top two chambers of the heart. The irregular heart rhythm may cause blood cl
China National Medical Products Administration (NMPA) Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for Chronic Hepatitis B Virus (HBV) Infection19.11.2018 06:00 | Tiedote
Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the China National Medical Products Administration (NMPA) has approved Vemlidy® (tenofovir alafenamide, TAF) 25 mg, a once-daily treatment for chronic hepatitis B in adults and adolescents (aged 12 years and older with body weight at least 35 kg). Vemlidy is a novel, targeted prodrug of tenofovir that has demonstrated antiviral efficacy similar to Gilead’s Viread® (tenofovir disoproxil fumarate, TDF) 300 mg but at one-tenth of the dose. Data show that because Vemlidy has greater plasma stability and more efficiently delivers tenofovir to hepatocytes compared to Viread, it can be given at a lower dose, resulting in less tenofovir in the bloodstream. In clinical trials, Vemlidy demonstrated improved renal and bone laboratory safety parameters compared to Viread. “With the approval of Vemlidy, physicians can now offer their patients a treatment that retains the efficacy of TDF while improving renal and bone safety parameters in cli
Celltrion Healthcare: Biosimilars Have the Potential to Deliver Dramatic Cost Savings for US and European Healthcare Systems19.11.2018 03:01 | Tiedote
Celltrion Healthcare outlined their vision of ‘shaping future healthcare by improving access to biosimilars’ at the 5th Annual Biosimilars USA Conference in New Jersey, US. Biosimilars offer healthcare providers and patients greater treatment choice and value, better access to treatments and improved patient outcomes. According to data provided by IMS Health, biosimilars could lead to cumulative savings of up to 107 billion USD by 2020 in the United States (US) and the top five European Union (EU) countries.1 The EU has made significant progress in unlocking the potential of biosimilars through continuous education of providers, payers and patients. This has been critical to EU biosimilar acceptance but has not been seen in the US, which has lagged behind. During a presentation on the opportunities and challenges presented by the use of biosimilars in the US, Celltrion Healthcare highlighted several challenges affecting the uptake of biosimilars within the US market. Both physicians an
Abu Dhabi to Host Interfaith Alliance For Safer Communities: Child Dignity in the Digital World Forum on 19 November17.11.2018 16:40 | Tiedote
Held under the patronage of His Highness Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces, the UAE will host the first edition of the Interfaith Alliance For Safer Communities Forum on November 19-20 in recognition of the country’s leading role in promoting tolerance and interfaith dialogue. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181117005008/en/ His Highness Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces (Photo: AETOSWire) The forum will host 450 guests including religious leaders, NGOs and heads of industry to discuss ongoing social challenges and develop comprehensive solutions for protecting youth from cybercrime. The Interfaith Alliance For Safer Communities Forum is an expansion of the Child Dignity in the Digital World Congress which was held in October 2017 in the Vatican, an
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme